0000950170-24-059638.txt : 20240514 0000950170-24-059638.hdr.sgml : 20240514 20240514163008 ACCESSION NUMBER: 0000950170-24-059638 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981007018 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 24944882 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 DEFA14A 1 defa14a_5-14-24.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )

 

 

Filed by the Registrant x

Filed by a Party other than the Registrant o

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

x

Definitive Additional Materials

o

Soliciting Material under §240.14a-12

ALKERMES PLC

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

x

No fee required.

o

Fee paid previously with preliminary materials.

o

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

On May 14, 2024, Alkermes plc (the “Company”) sent an email to employees in connection with the Company’s 2024 annual general meeting of shareholders. A copy of the communication can be found below.

 

 

 

Dear Colleagues,

 

Each year around this time, Alkermes holds its annual general meeting of shareholders (the Annual Meeting). In connection with the 2024 Annual Meeting, we published our Proxy Statement, a copy of which may be found by clicking here.

 

The Proxy Statement contains a series of proposals for our shareholders to consider and on which we ask that our shareholders vote. It also contains our Board’s recommendation as to how to vote on each proposal.

 

I am writing to encourage you to exercise your rights as a shareholder of Alkermes and vote your Alkermes shares before our 2024 Annual Meeting, which is being held on May 31, 2024. All employees who owned shares of Alkermes on March 18, 2024 (known as the ‘Record Date’ for the Annual Meeting) are entitled to vote.

 

Your vote is very important to the company, and we encourage you to vote as soon as possible. To be counted, your vote must be received by May 30, 2024 at 11:59 p.m. ET (4:59 a.m. IST).

 

Thank you for your support.